Seres Therapeutics Inc

XNAS:MCRB 4:00:00 PM EDT

12.70

-1.05 (-7.64%)

6:15:47 PM EDT: $12.77 +0.07 (+0.58%)

Market Cap (Intraday)	111.18M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$7.83 Million
Adjusted EPS	$0.46

See more estimates

10-Day MA	$15.12
50-Day MA	$18.18
200-Day MA	$13.89

See more pivots

Seres Therapeutics Inc Stock, XNAS:MCRB

101 Cambridge Park Drive, 4th floor, Cambridge, Massachusetts 02140

United States of America

Phone: +1.617.945.9626

Number of Employees: 233

http://www.serestherapeutics.com

Description

Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David A. Berry, and Noubar B. Afeyan on October 18, 2010 and is headquartered in Cambridge, MA.